3Dbiology_Banner

Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center

NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to talk about the value of cataloging proteins and the future...

/ March 20, 2017
Progression_Final_webBanner

The IO Revolution, Part 3 of 4: The Role of the Tumor in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this blog, we consider the role of the tumor in the...

/ March 9, 2017
sequencingProbes_crop

Live sequencing with the Hyb & Seq™ platform at AGBT 2017

“We wanted to make the world’s simplest sequencer,” remarked Joe Beechem, Ph.D., Senior Vice President of R&D at NanoString. Beechem presented the Hyb & Seq platform with live demonstration during a lunchtime workshop at the 2017 annual meeting of Advances...

/ February 24, 2017
3Dbiology_Banner

3D Biology™ Technology Measures DNA, RNA, and Protein Simultaneously

3D Biology™ Technology* Measures DNA, RNA, and Protein Simultaneously, Preserving Samples By Joe Beechem, Senior Vice President of Research and Development *For Research Use Only. Not for use in Diagnostic Procedures Too often I see scientists struggling to understand their...

Role_of_the_Host_Full-width

The IO Revolution, Part 2 of 4: The Role of the Host in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. In the next few blogs, we will consider how each of these sources of inter-patient heterogeneity has the potential to influence the...

/ January 12, 2017